D3, D1, AT1 Receptor Interaction--Genetic Hypertension
D3, D1, AT1 Receptor Interaction--Genetic Hypertension
批准号:
6781667
负责人:
Pedro A. Jose
金额:
$56.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-12-01 至 2008-11-30
关键词:
G protein coupled receptor kinaseangiotensin receptorblood pressureclinical researchdopamine receptorenzyme activityenzyme mechanismfamilial hypertensiongene interactiongenetic polymorphismgenetically modified animalsion transportkidney functionkidney pharmacologylaboratory mousepathologic processprotein protein interactionreceptor expressionrenal tubulerenin angiotensin systemsaluresissodium ion
中文摘要
Jose项目的总体目标是确定肾脏中D3、D1和AT1受体的相互作用。D3多巴胺受体可以独立于D1受体调节肾钠转运和血压,因为在小鼠中D3受体的破坏会增加血压并损害其急性生理盐水负荷的排泄能力。然而,D3受体也可以与D1受体协同作用以增加钠排泄。在遗传性高血压啮齿动物模型(Dahl盐敏感和自发性高血压大鼠,SHR)中,D3受体的利钠作用受损,D1和D3受体之间的相互作用丧失。遗传性高血压患者肾D1受体功能受损是由G蛋白偶联受体激酶4型(GRK4)活性升高引起的。GRK4基因位点与人类原发性高血压相关,GRK4变异与高血压相关。这些变体在中国仓鼠卵巢和HEK细胞中的异源表达会损害D1受体功能,而过表达GRK4变体A142V的小鼠会发生高血压,并对D1受体激动剂刺激的利钠反应受损。此外,抑制高血压患者肾近端小管细胞(或细胞系)的GRK4活性可恢复D1受体功能,选择性抑制GRK4表达可减轻SHRs患者血压升高。遗传性高血压患者的肾D3受体功能受损是否继发于GRK4活性升高,后者同时损害D1和D3受体,目前尚不清楚。然而,D3-/-小鼠D1受体功能受损,肾功能增高
英文摘要
The overall goal of Project by Jose is to determine D3, D1, and AT1 receptor interaction in the kidney. The D3 dopamine receptor can regulate renal sodium transport and blood pressure independent of the D1 receptor because disruption of the D3 receptor in mice increases blood pressure and impairs their ability to excrete an acute saline load. However, the D3 receptor can also synergistically interact with the D1 receptor to increase sodium excretion. In rodent models of genetic hypertension (Dahl salt sensitive and spontaneously hypertensive rat, SHR), the natriuretic effect of D3 receptors is impaired and the interaction between the D1 and D3 receptor is lost. The impairment of the renal D1 receptor function in genetic hypertension is caused by increased activity of G protein-coupled receptor kinase, type 4 (GRK4). GRK4 gene locus is linked to and GRK4 variants are associated with human essential hypertension. Heterologous expression of these variants in Chinese hamster ovary and HEK cells impairs D1 receptor function and mice overexpressing the GRK4 variant A142V develop hypertension and have an impaired natriuretic response to D1 receptor agonist stimulation. Moreover, inhibition of GRK4 activity in renal proximal tubule cells (or cell lines) from human hypertensives restores D1 receptor function and selective renal inhibition of GRK4 expression attenuates the increase in blood pressure in SHRs. Whether the impaired renal D3 receptor function in genetic hypertension is secondary to increased GRK4 activity, which impairs both the D1 and D3 receptor, is not known. However, D3-/- mice have impaired D1 receptor function, and increased renal
renin content and AT1 receptor. Thus, a decreased D1 receptor and an increased AT1 receptor function in D3-/- mice may contribute to their impaired ability to excrete a saline load and hypertension. The overall hypothesis of Project by Jose is that renal proximal tubule sodium transport is regulated, in part, by an interaction among D1, D3 and AT1 receptors, acutely, by receptor/receptor interaction, and chronically, by regulation of receptor expression. Moreover, in genetic hypertension, impaired D3 (and D1) receptor function due to increased GRK4 activity, allows unimpeded AT1 receptor action. Specific aim I will test the hypothesis that D3 receptor deficiency in mice both impairs D1 receptor function and allows unimpeded AT1 receptor function. Specific aim 2 will test the hypothesis that increased GRK4 activity, due to
constitutively active variants, impairs D3 receptor function in genetic hypertension. The results of these studies, using molecular biological and pharmacological tools, may shed light into the possibility that ability of GRK4 to regulate several genes may make GRK4 dysfunction a major cause of genetic hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
D2 receptor variation and renal dysfunction
-
批准号:10564943
-
项目类别:
-
资助金额:$70.6万
-
财政年份:2023
-
负责人:Pedro A. Jose
-
依托单位:
Lipid rafts, dopamine 1 receptor, and hypertension
-
批准号:9886774
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2020
-
负责人:Pedro A. Jose
-
依托单位:
Lipid rafts, dopamine 1 receptor, and hypertension
-
批准号:10544330
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2020
-
负责人:Pedro A. Jose
-
依托单位:
Lipid rafts, dopamine 1 receptor, and hypertension
-
批准号:10083735
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2020
-
负责人:Pedro A. Jose
-
依托单位:
Lipid rafts, dopamine 1 receptor, and hypertension
-
批准号:10319571
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2020
-
负责人:Pedro A. Jose
-
依托单位:
Ds receptor antioxidant activity and hypertension
-
批准号:8148031
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2010
-
负责人:Pedro A. Jose
-
依托单位:
Dopamine-1 Receptor Defect in Hypertension
-
批准号:7921095
-
项目类别:
-
资助金额:$17.2万
-
财政年份:2009
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:8123257
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:7658921
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:7908700
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:8266339
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
D5 Receptor Antioxidant Activity and Hypertension
-
批准号:7218286
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2006
-
负责人:Pedro A. Jose
-
依托单位:
Animal models of salt sensitivity: roles of GRK4 and sodium transporters on salt sensitivity
-
批准号:9283600
-
项目类别:
-
资助金额:$74.68万
-
财政年份:2004
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and D3R regulation of NHE3 and NCC expression
-
批准号:7778674
-
项目类别:
-
资助金额:$43.54万
-
财政年份:2004
-
负责人:Pedro A. Jose
-
依托单位:
D5 receptor antioxidant activity and hypertension
-
批准号:6656540
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2002
-
负责人:Pedro A. Jose
-
依托单位:
ONTOGENY OF DOPAMINE RECEPTOR/G-PROTEIN/EFFECTOR COUPLING
-
批准号:6346138
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2000
-
负责人:Pedro A. Jose
-
依托单位:
ONTOGENY OF DOPAMINE RECEPTOR/G-PROTEIN/EFFECTOR COUPLING
-
批准号:6201931
-
项目类别:
-
资助金额:$18.69万
-
财政年份:1999
-
负责人:Pedro A. Jose
-
依托单位:
ONTOGENY OF DOPAMINE RECEPTOR/G-PROTEIN/EFFECTOR COUPLING
-
批准号:6105772
-
项目类别:
-
资助金额:$18.69万
-
财政年份:1998
-
负责人:Pedro A. Jose
-
依托单位:
DOPAMINE-3 RECEPTOR SUBTYPE AND HYPERTENSION
-
批准号:6043980
-
项目类别:
-
资助金额:$22.07万
-
财政年份:1997
-
负责人:Pedro A. Jose
-
依托单位:
DOPAMINE-3 RECEPTOR SUBTYPE AND HYPERTENSION
-
批准号:2372962
-
项目类别:
-
资助金额:$21.01万
-
财政年份:1997
-
负责人:Pedro A. Jose
-
依托单位:
海外基金